About Johnson & Johnson
Industry:
Pharmaceuticals
Founded:
1886
Founders:
Robert Wood Johnson I, James Wood Johnson, Edward Mead Johnson
Status:
Public (NYSE: JNJ)
Funding & Growth
Total Raised:
N/A
Valuation:
$380B+ market cap
Stage:
Public
Key Investors:
Public markets
✓ Pros
- • One of the largest healthcare companies globally
- • Strong oncology (Janssen) pipeline
- • Excellent benefits and job stability
- • Multiple therapeutic areas
- • Strong R&D investment
✗ Cons
- • Very large company with bureaucracy
- • New Jersey location
- • Recent talc litigation concerns
- • Consumer health spin-off (Kenvue) changes